Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE–IIE extranodal natural killer/T-cell lymphoma, nasal type
Therapeutics and Clinical Risk Management Jun 13, 2018
Tong Q, et al. - Researchers retrospectively examined the salvage treatment outcomes and prognostic factors in patients with early stage locoregionally recurrent (LRR) extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTCL). Five hundred forty patients with stage IE–IIE ENKTCL received chemotherapy (ChT) and/or radiotherapy (RT) in the hospital, and among these, 56 patients who experienced LRR were involved in this investigation. In patients with LRR stage IE–IIE ENKTCL, salvage RT improved survival and the treatment toxicity was acceptable.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries